United Capital Financial Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-69,010
| Closed | -$3.33M | – | 1250 |
|
|
2021
Q1 | $3.33M | Buy |
69,010
+5
| +0% | +$241 | 0.02% | 417 |
|
|
2020
Q4 | $3.59M | Buy |
69,005
+9,140
| +15% | +$476K | 0.02% | 405 |
|
|
2020
Q3 | $1.6M | Sell |
59,865
-245
| -0.4% | -$6.56K | 0.01% | 553 |
|
|
2020
Q2 | $1.17M | Buy |
60,110
+4,750
| +9% | +$92.5K | 0.01% | 612 |
|
|
2020
Q1 | $545K | Hold |
55,360
| – | – | ﹤0.01% | 779 |
|
|
2019
Q4 | $614K | Sell |
55,360
-1,040
| -2% | -$11.5K | ﹤0.01% | 926 |
|
|
2019
Q3 | $316K | Buy |
56,400
+400
| +0.7% | +$2.24K | ﹤0.01% | 1053 |
|
|
2019
Q2 | $484K | Sell |
56,000
-3,000
| -5% | -$25.9K | ﹤0.01% | 1051 |
|
|
2019
Q1 | $440K | Sell |
59,000
-9,100
| -13% | -$67.9K | ﹤0.01% | 1011 |
|
|
2018
Q4 | $279K | Buy |
68,100
+47,000
| +223% | +$193K | ﹤0.01% | 1090 |
|
|
2018
Q3 | $118K | Sell |
21,100
-44,900
| -68% | -$251K | ﹤0.01% | 1289 |
|
|
2018
Q2 | $868K | Buy |
66,000
+16,000
| +32% | +$210K | 0.01% | 794 |
|
|
2018
Q1 | $710K | Sell |
50,000
-16,885
| -25% | -$240K | 0.01% | 862 |
|
|
2017
Q4 | $548K | Buy |
66,885
+8,835
| +15% | +$72.4K | ﹤0.01% | 937 |
|
|
2017
Q3 | $688K | Hold |
58,050
| – | – | 0.01% | 874 |
|
|
2017
Q2 | $583K | Buy |
58,050
+18,000
| +45% | +$181K | 0.01% | 892 |
|
|
2017
Q1 | $467K | Buy |
+40,050
| New | +$467K | ﹤0.01% | 924 |
|